Clinical Trial Update: Safety of Extracellular Vesicles for Burn Wounds [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety of extracellular vesicles for burn wound treatment, sponsored by Aegle Therapeutics, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Extracellular vesicle therapy (extracellular vesicles)

Snippet

Sponsor: Aegle Therapeutics | Conditions: Burns | Phase 1 | Status: COMPLETED